CIK 0001817241 · <br>Emerging growth company
Artiva Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARTV
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863614316
- Phone
- (858) 267-4467
- Business address
- 5505 MOREHOUSE DRIVE, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,341,159
- in 16 filings, $529K under 10b5-1 plans
Net −$2,341,159. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-27 | Banerjee Subhashis Chief Medical Officer | Option exercise 10b5-1 | +5,306 | $1.92 | $10K | 150,269 |
| 2026-08-27 | Banerjee Subhashis Chief Medical Officer | Sale 10b5-1 | −8,222 | $12.01 | $99K | 142,047 |
| 2026-08-27 | Banerjee Subhashis Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −5,306 | 74,265 | ||
| 2026-08-18 | Banerjee Subhashis Chief Medical Officer | Option exercise 10b5-1 | +429 | $1.92 | $824 | 145,392 |
| 2026-08-18 | Banerjee Subhashis Chief Medical Officer | Sale 10b5-1 | −429 | $12.00 | $5K | 144,963 |
| 2026-08-18 | Banerjee Subhashis Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −429 | 79,571 | ||
| 2026-07-31 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +24,944 | $9.93 | $248K | 17,329,570 |
| 2026-07-29 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +20,824 | $9.99 | $208K | 17,304,626 |
| 2026-07-24 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +41,319 | $9.99 | $413K | 17,283,802 |
| 2026-07-23 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +59,880 | $9.96 | $596K | 17,242,483 |
| 2026-07-22 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +84,124 | $9.93 | $835K | 17,182,603 |
| 2026-07-21 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +120,582 | $9.55 | $1.2M | 17,098,479 |
| 2026-07-17 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +7,882 | $8.95 | $71K | 16,977,927 |
| 2026-07-16 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +152,472 | $8.93 | $1.4M | 16,970,045 |
| 2026-07-13 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +6,522 | $8.94 | $58K | 16,817,543 |
| 2026-07-13 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +6,552 | $8.94 | $59K | 16,817,573 |
| 2026-07-10 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +15,102 | $8.97 | $135K | 16,811,021 |
| 2026-06-26 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +1,876 | $8.98 | $17K | 16,795,919 |
| 2026-06-25 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +31,000 | $8.88 | $275K | 16,794,043 |
| 2026-06-16 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +124,893 | $8.89 | $1.1M | 16,763,043 |
Page 3 of 11 · 203 trades